Health CanadaGeneral Alert

XELJANZ/XELJANZ XR (tofacitinib) – Risk of Major Adverse Cardiovascular Events, Malignancy, Thrombosis and Infection

Name: XELJANZ/XELJANZ XR (tofacitinib) – Risk of Major Adverse Cardiovascular Events, Malignancy, Thrombosis and Infection
Brand: Marketed health products
SKU: CANADA-63814
Availability: Discontinued
Rating: 1.0 (1 reviews)

Published: January 12, 2022Recall ID: 63814Category: generalCountry: Canada

Safety AlertHealth Canada Canada

Canada

XELJANZ/XELJANZ XR (tofacitinib) – Risk of Major Adverse Cardiovascular Events, Malignancy, Thrombosis and Infection

Recalling Firm: Marketed health products

Reason for Recall / Hazard

New safety information - Product safety

Product Description & Identification

XELJANZ/XELJANZ XR (tofacitinib) – Risk of Major Adverse Cardiovascular Events, Malignancy, Thrombosis and Infection

Affected Products

XELJANZ/XELJANZ XR (tofacitinib)

Additional Source Details

Field	Value
N I D	63814
U R L	https://recalls-rappels.canada.ca/en/alert-recall/xeljanzxeljanz-xr-tofacitinib-risk-major-adverse-cardiovascular-events-malignancy
Issue	New safety information - Product safety
Title	XELJANZ/XELJANZ XR (tofacitinib) – Risk of Major Adverse Cardiovascular Events, Malignancy, Thrombosis and Infection
Product	XELJANZ/XELJANZ XR (tofacitinib)
Archived	0
Category	Drugs
Last updated	2022-01-12
Organization	Marketed health products

Check Other Products In Your Household

Free Safety Tools

Safety recalls are issued daily across foods, medications, vehicles, and electronics. Use our instant tools to check your home for active safety warnings:

Barcode Scanner VIN Vehicle Check Pantry Safety Audit

Overview

Recalling FirmMarketed health products

Recall Hazard Severity

Caution (Class III)

Official Agency Alert

📢 Share Warning

Alert family and friends to keep them safe. Copy this quick alert message:

🚨 SAFETY ALERT: Marketed health products - XELJANZ/XELJANZ XR (tofacitinib) – Risk of Major Adverse Cardiovascular Events, Malignancy, Thrombosis and Infection

Check if your household is affected:
https://therecallfile.com/recalls/xeljanz-xeljanz-xr-tofacitinib-risk-of-major-adverse-cardiovascular-ev/CANADA-63814

WhatsApp Facebook

Join Alertlist

Get instant email updates whenever critical safety recalls like this are published.

Featured on Product Hunt

Help support our public safety mission and check out our community launch.

Support The Recall File

Help keep official recall alerts free, accessible, and fast for everyone.

Spread the WordXELJANZ/XELJANZ XR (tofacitinib) – Risk of Major Adverse Cardiovascular Events, Malignancy, Thrombosis and Infection

XELJANZ/XELJANZ XR (tofacitinib) – Risk of Major Adverse Cardiovascular Events, Malignancy, Thrombosis and Infection

XELJANZ/XELJANZ XR (tofacitinib) – Risk of Major Adverse Cardiovascular Events, Malignancy, Thrombosis and Infection

Reason for Recall / Hazard

Product Description & Identification

Affected Products

Additional Source Details

Check Other Products In Your Household

Overview

📢 Share Warning

Join Alertlist

Featured on Product Hunt

Support The Recall File

Install The Recall File App

Notification

XELJANZ/XELJANZ XR (tofacitinib) – Risk of Major Adverse Cardiovascular Events, Malignancy, Thrombosis and Infection

XELJANZ/XELJANZ XR (tofacitinib) – Risk of Major Adverse Cardiovascular Events, Malignancy, Thrombosis and Infection

Reason for Recall / Hazard

Product Description & Identification

Affected Products

Additional Source Details

Check Other Products In Your Household

Overview

📢 Share Warning

Join Alertlist

Featured on Product Hunt

Support The Recall File

Related Recalls

Transport Canada Recall - 2018088 -

Transport Canada Recall - 2018088 -

Transport Canada Recall - 2018288 -

Transport Canada Recall - 2018288 -

Transport Canada Recall - 2018409 -

Transport Canada Recall - 2018409 -

Install The Recall File App

Notification